Welcome to LookChem.com Sign In|Join Free

CAS

  • or

555155-07-2

555155-07-2

Post Buying Request

555155-07-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

555155-07-2 Usage

Chemical Properties

light yellow solid

Check Digit Verification of cas no

The CAS Registry Mumber 555155-07-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,5,1,5 and 5 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 555155-07:
(8*5)+(7*5)+(6*5)+(5*1)+(4*5)+(3*5)+(2*0)+(1*7)=152
152 % 10 = 2
So 555155-07-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H5FO2/c10-8-2-1-6(5-11)9-7(8)3-4-12-9/h1-5H

555155-07-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Fluorobenzofuran-7-carbaldehyde

1.2 Other means of identification

Product number -
Other names 4-fluoro-1-benzofuran-7-carbaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:555155-07-2 SDS

555155-07-2Downstream Products

555155-07-2Relevant articles and documents

Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV NS5B polymerase. Identification of ester prodrugs with improved oral pharmacokinetics

Venkatraman, Srikanth,Velazquez, Francisco,Gavalas, Stephen,Wu, Wanli,Chen, Kevin X.,Nair, Anilkumar G.,Bennett, Frank,Huang, Yuhua,Pinto, Patrick,Jiang, Yueheng,Selyutin, Oleg,Vibulbhan, Bancha,Zeng, Qingbei,Lesburg, Charles,Duca, Jose,Heimark, Larry,Huang, Hsueh-Cheng,Agrawal, Sony,Jiang, Chuan-Kui,Ferrari, Eric,Li, Cheng,Kozlowski, Joseph,Rosenblum, Stuart,Shih, Neng-Yang,George Njoroge

, p. 447 - 458 (2014/01/17)

HCV infections are the leading causes for hepatocellular carcinoma and liver transplantation in the United States. Recent advances in drug discovery have identified direct acting antivirals which have significantly improved cure rates in patients. Current

TRICYCLIC INDOLE DERIVATIVES AND METHODS OF USE THEREOF

-

Page/Page column 58; 59, (2010/01/07)

The present invention relates to Tricyclic Indole Derivatives, compositions comprising at least one Tricyclic Indole Derivatives, and methods of using the Tricyclic Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient

PURINE DERIVATIVES AS KINASE INHIBITORS

-

Page/Page column 46, (2008/06/13)

The present invention provides kinase inhibitors of Formula I.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 555155-07-2